MICRONOMICIN SULFATE
CAS66803-19-8
MICRONOMICIN SULFATE (CAS 66803-19-8, C20H41N5O7.H2SO4) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 66803-19-8
- Formula
- C20H41N5O7.H2SO4
- Mol. weight
- 561.65 g/mol
Chemical Specifications
Identifiers
| CAS number | 66803-19-8 |
|---|---|
| Product name | MICRONOMICIN SULFATE |
| Chinese name | 沙加霉素 |
| Synonyms | streptamine,o-2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-alpha-d-erythro-hexop |
| Chinese synonyms | 硫酸小诺霉素; 硫酸小诺米星; 沙加霉素; 相模霉素; 小诺米星; 硫酸沙加霉素; 硫酸相模霉素; 硫酸小诺米星/硫酸沙加霉素 |
| Molecular formula | C20H41N5O7.H2SO4 |
| Molecular weight | 561.65 g/mol |
Physical and chemical properties
| Boiling Point | 357.3 ( ℃ ) |
|---|
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of MICRONOMICIN SULFATE?
The CAS Registry Number of MICRONOMICIN SULFATE is 66803-19-8. MICRONOMICIN SULFATE is also known as streptamine,o-2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-alpha-d-erythro-hexop.
What is the molecular formula and molecular weight of MICRONOMICIN SULFATE?
The molecular formula of MICRONOMICIN SULFATE is C20H41N5O7.H2SO4, and its molecular weight is 561.65 g/mol.
How can I request a quotation for MICRONOMICIN SULFATE?
Send an inquiry for MICRONOMICIN SULFATE (CAS 66803-19-8) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for MICRONOMICIN SULFATE
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.